Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Hold
13,563
1.04% 19
2026
Q1
$1.64M Hold
13,563
1.74% 17
2025
Q4
$1.44M Hold
13,563
1.45% 17
2025
Q3
$1.15M Hold
13,563
1.28% 19
2025
Q2
$1.08M Hold
13,563
1.4% 19
2025
Q1
$1.23M Hold
13,563
1.75% 17
2024
Q4
$1.36M Hold
13,563
1.82% 18
2024
Q3
$1.55M Hold
13,563
2.4% 13
2024
Q2
$1.69M Hold
13,563
2.71% 9
2024
Q1
$1.8M Hold
13,563
3.17% 9
2023
Q4
$1.49M Hold
13,563
2.85% 10
2023
Q3
$1.41M Hold
13,563
2.85% 10
2023
Q2
$1.57M Hold
13,563
2.99% 9
2023
Q1
$1.45M Hold
13,563
3% 10
2022
Q4
$1.51M Hold
13,563
2.72% 14
2022
Q3
$1.18M Hold
13,563
2.66% 12
2022
Q2
$1.25M Hold
13,563
2.95% 10
2022
Q1
$1.12M Hold
13,563
2.34% 12
2021
Q4
$1.04M Hold
13,563
2.13% 12
2021
Q3
$1.03M Buy
+13,563
New +$1.03M 2.4% 12

Other funds holding MRK

Boxwood Ventures's MRK Position: Q2 2026 in Review

Boxwood Ventures held its Merck (MRK) position steady in Q2 2026 at 13,563 shares worth $1.74M. The position accounts for 1.04% of the portfolio, ranked #19.

Boxwood Ventures first reported a position in MRK in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.8M in Q1 2024. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Boxwood Ventures held 13,563 shares of Merck worth $1.74M as of Q2 2026.
  • Boxwood Ventures left its Merck share count unchanged in Q2 2026.
  • Merck made up 1.04% of Boxwood Ventures's portfolio in Q2 2026, its #19 holding.
  • Boxwood Ventures first reported a position in Merck in Q3 2021 and has held it in 20 quarters since.
  • Boxwood Ventures's Merck position peaked at $1.8M in Q1 2024.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Boxwood Ventures's 13F filing for Q2 2026, filed 12 Aug 2026.